cannabis stock news – MJ Shareholders

3 Marijuana Stocks To Keep On Watch After Q4 Earnings

MJ Shareholders — Sat, 22 Mar 2025 05:29:00 +0000

Top Marijuana Stocks For Investors To Know 2025

Marijuana stocks are still having issues catching bigger waves of momentum. Even with most cannabis companies reporting strong Q4 earnings it only did so much for the public sector. Many feel as more reform and regulatory issues are met in favor of legal operators it will help the public sector. The biggest fight for legal cannabis is better laws in place that help legal operators, not just corporate cannabis. There are many parts to what makes a strong industry and a solid company.

For the most part, companies that are profitable or are working on big projects seem to catch the volatile pops in trading. Even with the current volatile downtrend at times when there is a strong enough catalyst cannabis stocks have seen jumps in trading. Yet often they are short-lived it still give shareholders a chance to potentially make a profit. Right now investors see cannabis stocks as the investment of the future.

So as the sector is down some see it as a means to find the best marijuana stocks to buy. Better to find the top companies at low share prices than a pot stock that has a low entry but doesn’t trade well. Having a good strategy and taking the time to do your due diligence is important. Below are several marijuana stocks to watch as investors watch for any upward market changes.

Top Marijuana Stocks For Investors 2025

FLUENT Corp. (OTC:CNTMF)
Curaleaf Holdings, Inc. (OTC:CURLF)
Ascend Wellness Holdings, Inc (OTC:AAWH)

FLUENT Corp.

FLUENT Corp., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. At the end of February 2025 the relocation of its Miami dispensary from North Miami Beach to Aventura.

Words From The Company

“As our store in North Miami Beach was an outdated first-generation store, our newly opened Aventura location is reflective of FLUENT’s current store model boasting many updates such as an open showroom floor, digital menu screens, an expanded vault and twice the number of POS stations,” said Robert Beasley, CEO of FLUENT.”

Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. On March 3rd the company reported its Q4 and full-year 2024 results.

Fourth Quarter 2024 Financial Highlights

Net Revenue of $331.1 million, a year-over-year decrease of 4% compared to Q4 2023 revenue of $345.3 million.
Gross profit of $157.4 million and gross margin of 48%, an increase of 230 basis points year-over-year.
Adjusted gross profit(1) of $158.7 million and adjusted gross margin(1) of 48%, an increase of 150 basis points year-over-year.
Net loss attributable to Curaleaf Holdings, Inc. from continuing operations of $71.8 million.
Cash at quarter end totaled $107.2 million.

Ascend Wellness Holdings, Inc

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.

Q4 2024 Earnings And Highlights

Full Year 2024 Net Revenue Increased 8% Year-over-Year to $562 million
Full Year 2024 Adjusted EBITDA1 Increased 9% Year-over-Year to $116 million
Second Full Year of Positive Cash from Operations and Positive Free Cash Flow2
Company Ended Q4 2024 with $88 Million of Cash and Cash Equivalents

The post 3 Marijuana Stocks To Keep On Watch After Q4 Earnings appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results

MJ Shareholders — Wed, 19 Mar 2025 17:29:13 +0000

Charlotte’s Web Reports 2024 Fourth Quarter and Year-End Financial Results

Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), a market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year-ended December 31, 2024.

2024 Business Highlights

Achieved sequential quarterly revenue growth throughout 2024

Reduced operating expenses by over $22.4 million while strengthening operational performance

Successfully launched a new e-commerce platform with significantly enhanced capabilities

Expanded retail distribution, including 847 Walmart stores and now with a presence on Walmart.com, as well as Chewy.com, America’s largest online pet retailer

Introduced new product innovations, including functional mushroom gummies and CBD gel caps

Reduced operating expenses by over $22.4 million while strengthening operational performance

“2024 marked a turning point for Charlotte’s Web operationally as we delivered consecutive quarterly revenue growth, strengthened operations, and positioned the Company for sustained growth in 2025,” said Bill Morachnick, Chief Executive Officer of Charlotte’s Web. “With the successful launch of new product innovations, expanded retail partnerships, and transition underway to in-house manufacturing, we have laid the foundation for further strengthening the business in 2025. We’re particularly excited to announce that we will soon be offering our functional mushroom gummies on Amazon.com, representing our first meaningful presence on Amazon and introducing the Charlotte’s Web brand to millions of potential new customers. This not only diversifies our revenue streams but also reflects our commitment to access, including where consumers increasingly purchase health and wellness products. We are committed to delivering shareholder value through disciplined execution and continued expansion, evolving as a broader botanical wellness leader, beyond CBD.”

“Disciplined expense and cash flow management were top priorities throughout 2024,” added Erika Lind, Chief Financial Officer. “Our omnichannel strategy and operational optimization have been instrumental in navigating a complex regulatory environment while improving our cost structure. We executed significant expense reductions, reduced cash burn, and improved efficiencies across the business. The substantial improvement in our fourth quarter Adjusted EBITDA1 performance reflects the effectiveness of these measures, positioning us to continue reducing cash burn as we approach positive cash flow. We anticipate further improvements in 2025.”

2024 Business Review

Charlotte’s Web made significant strides in 2024, stabilizing its business and advancing strategic initiatives across product innovation, retail expansion, and operational efficiency.

Omnichannel Expansion and E-Commerce Growth
The Company’s new e-commerce platform, launched in mid-2024, improved site performance, enhanced the shopping experience and drove higher customer engagement. Advanced customer tools and marketing automation have increased conversion rates and sales volumes. New retail partnerships were added, including Walmart for topicals and Chewy.com for pet wellness products, further strengthening Charlotte’s Web’s national footprint. The transition toward an omnichannel model allows Charlotte’s Web to leverage direct-to-consumer (DTC), retail, and third-party platforms, streamlining distribution while broadening consumer accessibility.

New Product Innovations
New product innovations and categories included a successful expansion into minor cannabinoid CBN with the launch of Stay Asleep CBN Gummies, demonstrating strong demand for targeted botanical solutions and reinforcing Charlotte’s Web’s position in sleep wellness. In addition, launched in Q4 2024, Charlotte’s Web expanded into botanical wellness beyond CBD with functional mushroom gummies for focus, stress support, and energy.

Operational Efficiencies and Cost Management
Preparation for in-house manufacturing of gummies for full commercial production progressed in Q4 2024, with production ramp-up expected in 2025, improving margins and enhancing speed-to-market for future innovations. Expense reductions initiated in early 2024 materially lowered operating costs by $22.4 million, with similar spending continuing in 2025. The Company ended 2024 with $22.6 million in cash reserves, and the discipline of stringent expense management supports a strategic roadmap toward positive cash flow.

“With deeper retail penetration, new product categories, and improved operational efficiencies, we enter 2025 with momentum,” added Morachnick. “Charlotte’s Web is positioned to lead the next growth phase in botanical wellness while creating lasting value for shareholders.”

DeFloria Milestone
On February 24, 2025, the Company announced that the U.S. Food and Drug Administration (“FDA”) completed its review of the Phase 1 data and Investigational New Drug (“IND”) application submitted by DeFloria, Inc., an entity in which the Company is a stakeholder. The FDA has concluded that DeFloria may now proceed with the Phase 2 clinical trial for its botanical pharmaceutical candidate, AJA001 Oral Solution, a treatment for symptoms of autism spectrum disorder (“ASD”).

DeFloria is a collaboration between Charlotte’s Web, Ajna Biosciences, and British American Tobacco to develop AJA001 as a treatment for irritability associated with autism spectrum disorder. AJA001 employs the Company’s proprietary full-spectrum cannabidiol hemp extract derived from one of its patented cultivars. Charlotte’s Web has rights related to manufacturing for any eventual commercialization of AJA001 as an FDA-regulated botanical drug. Being the manufacturer of this product could represent a substantial long-term revenue opportunity for Charlotte’s Web upon potential FDA approval.

Financial Review

The following table sets forth selected financial information for the periods indicated:

Three months ended

Year ended

December 31,

U.S. $ millions, except per share data

2024

2023

2024

2023

Revenue

$ 12.7

$ 15.9

$ 49.7

$ 63.2

Cost of goods sold

$ 7.6

$ 7.0

$ 28.4

$ 27.6

Gross profit

5.1

8.9

21.3

35.6

Selling, general and administrative expenses

10.6

18.6

53.3

75.6

Goodwill and asset impairments

–

0.6

–

0.6

Operating loss

(5.5)

(10.3)

(32.0)

(40.6)

Gain on initial investment in unconsolidated entity

–

10.7

Change in fair value of financial instruments and other

(0.1)

3.7

0.6

9.3

Other income (expense) , net

2.2

(1.4)

1.6

(2.7)

Income tax expense

–

(0.5)

–

(0.5)

Net loss

$ (3.4)

$ (8.5)

$ (29.8)

$ (23.8)

EPS basic and diluted

$ (0.02)

$ (0.06)

$ (0.19)

$ (0.16)

Adjusted EBITDA

$ 0.3

$ (6.5)

$ (12.6)

$ (22.7)

Assets:

Dec 31, 2024

Dec 31, 2023

Cash and cash equivalents

$ 22.6

$ 47.8

Total assets

$ 113.4

$ 152.5

Liabilities:

Long-term liabilities

$ 70.4

$ 73.3

Total liabilities

$ 86.4

$ 97.0

Fourth Quarter 2024 Financial Review

Consolidated net revenue for the fourth quarter ended December 31, 2024, was $12.7 million, compared to $15.9 million in the fourth quarter of 2023. Revenue increased modestly on a quarter-over-quarter basis versus Q3 2024 revenue of $12.6 million.

Quarterly revenue trend for 2024:

U.S. $ millions

2024

Total revenue

$ 12.1

$ 12.3

$ 12.6

$ 12.7

In the fourth quarter, some retailers were negatively impacted by state regulations restricting the sale of certain CBD products, despite meeting federal requirements. However, e-commerce revenue increased quarter-over-quarter following the launch of the Company’s new e-commerce platform.

Gross Profit in Q4 2024 was $5.1 million, or 40.2% of revenue, compared to Gross Profit of $8.9 million, or 56.0% of revenue, in Q4 2023. The reduction in gross margin reflected holiday promotional investments, temporary shipping inefficiencies, and reduced fixed cost absorption on lower-than-expected revenue. The Company models gross margin to return above 50% in 2025.

Total selling, general, and administrative (“SG&A”) expenses in the quarter were $10.6 million, a 43% improvement from $18.6 million in Q4 2023. Stringent expense controls were implemented during the year to better align with current revenue levels.

Net loss for the fourth quarter of 2024 was $3.4 million, or ($0.02) per share basic and diluted, compared to a net loss of $8.5 million, or ($0.06) per share basic and diluted, for the fourth quarter of 2023.

Excluding depreciation, amortization and other non-cash items, Charlotte’s Web reported positive Adjusted EBITDA1 for the fourth quarter of 2024 of $0.3 million, a $6.8 million improvement compared to negative Adjusted EBITDA of $6.5 million in the fourth quarter of 2023.

Fiscal Year 2024 Financial Review
On a year-over-year basis, consolidated net revenue for the twelve months ended December 31, 2024, was $49.7 million, a decrease of 21.4% from $63.2 million in 2023. Revenue was negatively impacted by inflationary impacts on consumer spending and reduced retailer shelf allocations to the CBD category. The Company adopted a new e-commerce platform mid-year that has resulted in improving marketing, customer management, and sales volumes.

Gross profit for the year ended December 31, 2024, was $21.3 million, compared to $35.6 million for the year ended December 31, 2023. Gross profit was negatively impacted by a $4.1 million increase in inventory provision for 2024 due to the revaluation of aged hemp based on current market conditions. The increase was partially offset by lower inventory expenses and other variable costs associated with lower revenue in 2024. Gross profit before inventory provision was $25.4 million, or 51.1%, and $36.6 million, or 58.0%, in 2024 and 2023, respectively.

Total SG&A expense for 2024 was $53.3 million, compared to $75.6 million in the prior year. The $22.4 million or 29.6% decrease resulted from multiple actions taken in 2024 to reduce operating expenses and better align SG&A against the lower revenue levels, including workforce and insurance program adjustments, contract reviews and negotiations, and software optimizations. Additionally, in 2024, the Company amended its MLB Promotional Rights Agreement, resulting in a decrease in amortization and media expense related to MLB assets of approximately $4.9 million compared to 2023.

An operating loss of $32 million in 2024 improved 21.2% from an operating loss of $40.6 million in 2023. Net loss for 2024 was $29.8 million, or $(0.19) per share, basic and diluted, compared to a net loss of $23.8 million, or $(0.16) per share, basic and diluted, in 2023. The lower net loss in 2023 was due to a combined net gain of $20.0 million in that year in the fair value of the Company’s debt derivative and from its investment in DeFloria.

Excluding depreciation, amortization, and interest, the EBITDA1 loss for 2024 was $17.6 million, as compared to an EBITDA loss of $6.3 million for 2023. 2024 included a higher inventory provision than 2023, which included the combined net gain of $20.0 million in fair value of the Company’s debt derivative and from its investment in DeFloria. Excluding these items, the Adjusted EBITDA1 loss was $12.6 million for 2024, as compared to the Adjusted EBITDA loss of $22.7 million for 2023.

Balance Sheet and Cash Flow
Net cash used for operations in the fourth quarter of 2024 was $1.8 million. Net cash used for operations in the year ended December 31, 2024, was $21.2 million, including cash paid to MLB for license and media rights assets of $5 million. Capital expenditures of $3.9 million were primarily used for the in-house production of topical and gummy projects.

The Company’s cash and working capital as of December 31, 2024, were $22.6 million and $31.1 million, respectively, compared to $47.8 million and $54.5 million as of December 31, 2023, respectively.

“With reduced cash burn, having cash reserves exceeding $22 million provides the runway for 2025 growth and beyond,” said Mrs. Lind. “In-house production will increase in 2025, and continued expense discipline is key to stabilizing our financial position.”

Consolidated Financial Statements and Management’s Discussion and Analysis
The Company’s audited consolidated financial statements and accompanying notes for the three and twelve-month periods ended December 31, 2024, and 2023, and related management’s discussion and analysis of financial condition and results of operations (“MD&A”), are reported in the Company’s 10-K filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR+ at www.sedarplus.ca and will be available on the Investor Relations section of the Company’s website at https://investors.charlottesweb.com.

Analyst Conference Call
Management will host a conference call to discuss the Company’s 2024 fourth quarter and year-end results at 11:00 A.M. ET on March 19, 2025.

There are three ways to join the call:

Dial 1-646-357-8785 or 1-800-836-8184 approximately 10 minutes before the conference call, or

Listen to the live webcast online.

Earnings Call Replay
A recording of the call will be available through March 26, 2025. To listen to a replay of the earnings call, please dial 1- 646-517-4150 or 1-888-660-6345 and provide conference replay ID 90317#. A webcast of the call will also be accessible through the investor relations section of the Company’s website for an extended period of time.

Subscribe to Charlotte’s Web investor news.

About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Louisville, Colorado, is the market leader in innovative hemp extract wellness products that include Charlotte’s Web whole-plant full-spectrum CBD extracts as well as broad-spectrum CBD certified NSF for Sport®. Charlotte’s Web branded premium quality full-spectrum CBD extract products start with proprietary hemp genetics that are North American farm-grown using organic and regenerative cultivation practices. The Company’s hemp extracts have naturally occurring botanical compounds including cannabidiol (“CBD”), CBN, CBC, CBG, terpenes, flavonoids, and other beneficial compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, calming, exercise recovery, immunity), CBN gummies, functional mushroom gummies, CBD capsules, CBD topical creams, and lotions, as well as CBD pet products for dogs. Through its substantially vertically integrated business model, Charlotte’s Web maintains stringent control over product quality and consistency with analytic testing from soil to shelf for quality assurance. Charlotte’s Web products are distributed to retailers and healthcare practitioners throughout the U.S.A. and online through the Company’s website at www.charlottesweb.com.

Shares of Charlotte’s Web trade on the Toronto Stock Exchange (TSX) under the symbol “CWEB” and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol “CWBHF”.

Charlotte’s Web is the official CBD of Major League Baseball©.

(1)

Non-GAAP Measures: The press release contains non-GAAP measures, including EBITDA and Adjusted EBITDA. Please refer to the section in the tables captioned “Non-GAAP Measures” below for additional information and a reconciliation to GAAP for all Non-GAAP metrics.

Forward-Looking Information
Certain information provided herein constitutes forward-looking statements or information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as “may”, “will”, “should”, “could”, “anticipate”, “expect”, “project”, “estimate”, “forecast”, “plan”, “intend”, “target”, “believe” and similar words suggesting future outcomes or statements regarding an outlook. Forward-looking statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate and reasonable.

Specifically, this press release contains forward-looking statements relating to, but not limited to: organizational changes, marketing plans and operational platform upgrades, and the impact of these initiatives on retail expansion, operational efficiencies, cash flow,‎ revenue and e-commerce monetization; expectations relating to IT upgrades, marketing optimization and operational integrations; product expansion activities and the corresponding ‎results thereof; sales volume ad gross margin expectations; anticipated timing for, and business impact of, in-house manufacturing of topical ‎and gummy products; ‎the impact of the Company’s product innovations on product development; regulatory developments and the impact of developments on both consumer action and the Company’s opportunities and operations; activities relating to, and sponsorship of, legislation to advance regulatory framework; the impact of insourcing on operating margins, capital expenditures and R&D; anticipated consumer trends and corresponding product innovation; anticipated future financial results; the impact of the Company’s partnership with the MLB and PLL on the Company’s exposure and sales; the Company’s ability to increase online traffic and demographic exposure through new products and marketing; and the impact of certain activities on the Company’s business and financial condition and anticipated trajectory.

The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to: regulatory regime changes; anticipated product development and sales; the success of sales and marketing activities; product development and production expectations; outcomes from R&D activities; the Company’s ability to deal with adverse growing conditions in a timely and cost-effective manner; the availability of qualified and cost-effective human resources; compliance with contractual and regulatory obligations and requirements; availability of adequate liquidity and capital to support operations and business plans; and expectations around consumer product demand. In addition, the forward-looking statements are subject to risks and uncertainties pertaining to, among other things: supply and distribution chains; the market for the Company’s products; revenue fluctuations; regulatory changes; loss of customers and retail partners; retention and availability of talent; competing products; share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; economic and political considerations; and including but not limited to those risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ending December 31, 2024, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available on www.sedarplus.ca. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company’s future course of action depends on management’s assessment of all information available at the relevant time.

Any forward-looking statement in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. Except as required by applicable law, the Company assumes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company’s behalf, are expressly qualified in their entirety by these cautionary statements.

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands of U.S. dollars, except share and per share amounts)

December 31,

2024

2023

ASSETS

Current assets:

Cash and cash equivalents

$ 22,618

$ 47,820

Accounts receivable, net

1,263

1,950

Inventories, net

18,907

21,538

Prepaid expenses and other current assets

4,194

6,864

Total current assets

46,982

78,172

Property and equipment, net

26,337

27,513

License and media rights

13,691

17,070

Operating lease right-of-use assets, net

12,876

14,601

Investment in unconsolidated entity

10,800

11,000

SBH purchase option and other derivative assets

1,075

2,602

Intangible assets, net

1,049

887

Other long-term assets

632

703

Total assets

$ 113,442

$ 152,548

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$ 3,426

$ 2,860

Accrued and other current liabilities

5,246

8,682

Lease obligations – current

2,055

2,252

License and media rights payable – current

5,209

9,852

Total current liabilities

15,936

23,646

Convertible debenture

43,631

42,528

Lease obligations

13,652

15,655

License and media rights payable

11,809

11,338

Derivative and other long-term liabilities

1,327

3,823

Total liabilities

86,355

96,990

Commitments and contingencies

Shareholders’ equity:

Common shares, nil par value; unlimited shares authorized; 158,009,541 and 154,332,366 shares issued and outstanding as of December 31, 2024 and 2023, respectively

Additional paid-in capital

328,655

327,280

Accumulated deficit

(301,569)

(271,723)

Total shareholders’ equity

27,087

55,558

Total liabilities and shareholders’ equity

$ 113,442

$ 152,548

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands of U.S. dollars, except share and per share amounts)

Year Ended December 31,

2024

2023

Revenue

$ 49,667

$ 63,155

Cost of goods sold

28,407

27,589

Gross profit

21,260

35,566

Selling, general and administrative expenses

53,247

75,630

Asset impairment

—

548

Operating loss

(31,987)

(40,612)

Gain on initial investment in unconsolidated entity

—

10,700

Change in fair value of financial instruments

615

9,339

Other income (expense), net

1,565

(2,694)

Loss before provision for income taxes

$ (29,807)

$ (23,267)

Income tax expense

(39)

(529)

Net loss

$ (29,846)

$ (23,796)

Per common share amounts

Net loss per common share, basic and diluted

$ (0.19)

$ (0.16)

CHARLOTTE’S WEB HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands of U.S. dollars, except share amounts)

Common Shares

Additional
Paid-in
Capital

Accumulated
Deficit

Total
Shareholders’
Equity

Amount

Balance—December 31, 2022

152,135,026

$ 1

$ 325,431

$ (247,927)

$ 77,505

Common shares issued upon vesting of restricted share units, net of withholdings

2,197,340

—

(251)

—

(251)

Share-based compensation

—

2,100

—

2,100

Net loss

—

(23,796)

Balance—December 31, 2023

154,332,366

$ 1

$ 327,280

$ (271,723)

$ 55,558

Common shares issued upon vesting of restricted share units, net of withholding

3,677,175

—

(145)

—

(145)

Share-based compensation

—

1,520

—

1,520

Net loss

—

(29,846)

Balance—December 31, 2024

158,009,541

$ 1

$ 328,655

$ (301,569)

$ 27,087

CHARLOTTE’S WEB HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of U.S. dollars)

Year Ended December 31,

2024

2023

Cash flows from operating activities:

Net loss

$ (29,846)

$ (23,796)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation and amortization

9,979

15,160

Change in fair value of financial instruments

(615)

(9,339)

Gain on initial investment in unconsolidated entity

—

(10,700)

Convertible debenture and other accrued interest

3,724

3,857

Gain on foreign currency transaction

(3,631)

1,142

Share-based compensation

1,520

2,100

Changes in right-of-use assets

1,771

1,918

Allowance for credit losses

140

1,240

Inventory provision

4,154

1,039

Asset impairment

—

548

Other

611

3,313

Changes in operating assets and liabilities:

Accounts receivable, net

361

(809)

Inventories, net

(1,520)

4,376

Prepaid expenses and other current assets

1,332

Operating lease obligations

(2,247)

(2,304)

Accounts payable, accrued and other liabilities

(1,664)

151

License and media rights payable

(5,000)

(8,000)

Income tax and other receivable

—

4,261

Other operating assets and liabilities, net

(330)

372

Net cash used in operating activities

(21,261)

(15,386)

Cash flows from investing activities:

Purchases of property and equipment and intangible assets

(3,851)

(3,691)

Proceeds from sale of assets

185

Net cash provided by/(used in) investing activities

(3,796)

(3,506)

Cash flows from financing activities:

Other financing activities

(145)

(251)

Net cash used in financing activities

(145)

(251)

Net decrease in cash and cash equivalents

(25,202)

(19,143)

Cash and cash equivalents —beginning of year

47,820

66,963

Cash and cash equivalents —end of year

$ 22,618

$ 47,820

Non-cash activities:

Non-cash issuance of note receivable

—

(170)

Non-cash purchases of property and equipment and intangibles

(3)

(233)

(1) Non-GAAP Measures – EBITDA and Adjusted EBITDA
Earnings before interest, taxes, depreciation, and amortization (“EBITDA”) is not a recognized performance measure under U.S. GAAP. The term EBITDA consists of net loss and excludes interest, taxes, depreciation, and amortization. Adjusted EBITDA also excludes other non-cash items such as changes in fair value of financial instruments (Mark-to-Market), Share-based compensation, and impairment of assets. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The non-GAAP financials measures do not have a standardized meaning prescribed under U.S. GAAP and therefore may not be comparable to similar measures presented by other issuers. The primary purpose of using non-GAAP financial measures is to provide supplemental information that we believe may be useful to investors and to enable investors to evaluate our results in the same way we do. We also present the non-GAAP financial measures because we believe they assist investors in comparing our performance across reporting periods on a consistent basis, as well as comparing our results against the results of other companies, by excluding items that we do not believe are indicative of our core operating performance. Specifically, we use these non-GAAP measures as measures of operating performance; to prepare our annual operating budget; to allocate resources to enhance the financial performance of our business; to evaluate the effectiveness of our business strategies; to provide consistency and comparability with past financial performance; to facilitate a comparison of our results with those of other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and in communications with our board of directors concerning our financial performance. Investors should be aware, however, that not all companies define these non-GAAP measures consistently.

(1)

EBITDA and Adjusted EBITDA are non-GAAP financial measures with reconciliations provided in the table below:

Adjusted EBITDA for the three and twelve months ended December 31, 2024, and 2023 is as follows:

Charlotte’s Web Holdings, Inc.

Statement of Adjusted EBITDA

(In Thousands)

Three Months Ended

Year Ended

December 31,

(unaudited)

(audited)

U.S. $ Thousands

2024

2023

2024

2023

Net loss

$ (3,371)

$ (8,589)

$ (29,846)

$ (23,796)

Depreciation of property and equipment and amortization of intangibles

2,473

3,650

9,979

15,160

Interest (income) expense

643

350

2,201

1,786

Income tax expense

(22)

529

EBITDA

(277)

(4,060)

(17,627)

(6,321)

Stock Comp

223

454

1,520

2,100

Mark-to-market financial instruments

(3,752)

(615)

(9,339)

Impairment

–

548

–

548

Inventory Provision

228

309

4,154

1,039

Initial gain on investment in DeFloria

–

(10,700)

Adjusted EBITDA

$ 260

$ (6,501)

$ (12,568)

$ (22,673)

View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reports-2024-fourth-quarter-and-year-end-financial-results-302405400.html

SOURCE Charlotte’s Web Holdings, Inc.

The post Charlotte’s Web Holdings, Inc. (CWBHF) Reports 2024 Fourth Quarter and Year-End Financial Results appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Cronos Group Inc. (CRON) Appoints Anna Shlimak as Chief Financial Officer

MJ Shareholders — Wed, 19 Mar 2025 17:29:11 +0000

Cronos Appoints Anna Shlimak as Chief Financial Officer

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.

Ms. Shlimak has been an integral part of Cronos’ leadership team for the last seven years, playing a key role in shaping the Company’s strategy, operational efficiencies, and engagement with the financial and investment community. During her tenure, she has led many strategic initiatives including cost optimization, revenue growth, and building Cronos’ corporate brand, which have positioned the Company for long-term success.

“I am incredibly pleased Anna Shlimak is stepping into the Chief Financial Officer role,” said Mike Gorenstein, President and Chief Executive Officer, Cronos. “Anna has been an essential part of our senior leadership team. With a deep understanding of our business and a proven track record of driving financial performance, operational efficiency and strategic growth, Anna is the ideal leader to help drive our financial strategy and next phase of growth.

Mr. Gorenstein continued, “I want to sincerely thank James for his contributions to Cronos. He played an important role in improving our finance functions and has worked to build a robust Finance team. His commitment to Cronos has been essential and I thank James for everything he’s contributed to the Company and wish him all the best in his future endeavors.”

Mr. Holm said, “I’m incredibly proud of what we’ve accomplished over the past two and a half years and look forward to watching the Cronos team continue to deliver strong results. Under Anna’s leadership, I’m confident the Company will continue to grow and lead the cannabis industry on a global scale.”

Ms. Shlimak said, “I am honored to step into the role of CFO and continue working alongside our talented teams. Cronos is committed to building exceptional cannabis brands and products that enhance experiences, and I am excited to lead our financial and strategic growth as we continue to expand and drive performance. As we enter the next phase of growth, I look forward to driving long-term value for our shareholders, employees, and consumers.”

About Anna Shlimak
Anna recently served as the Company’s Chief Strategy Officer and was responsible for managing and directing the organization’s corporate strategy, investor relations, communications, government affairs, and information systems departments. Prior to joining Cronos, Anna was the Head of Investor Relations at Quest Partners LLC, a research-driven alternative investment firm. Anna was responsible for business development, investor reporting, marketing, and communication initiatives for the fund. Before that, Anna held a range of roles at the New York Stock Exchange in both the New York and London offices. She received a Master of Business Administration from Columbia Business School and holds a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.

About Cronos Group Inc.
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about transition plans with respect to the Company’s Chief Financial Officer role; the Company’s growth, industry leadership, success and financial strategy; long-term value for the Company’s shareholders, employees and consumers; and the Company’s intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Media Relations Contact:
Emily Whalen
Communications
Tel: (416) 504-0004
media.relations@thecronosgroup.com

Investor Relations Contact:
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

The post Cronos Group Inc. (CRON) Appoints Anna Shlimak as Chief Financial Officer appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

2 Top Pot Stocks To Watch As More Companies Report Earnings

MJ Shareholders — Sun, 16 Mar 2025 09:28:47 +0000

Here Are 2 Cannabis Stocks That Could Make You Money

Despite the battle to see progress for cannabis stocks in the market cannabis companies are generally doing well. Often in the form of revenue due to several factors. Which involves the progress of the legalization of marijuana for both recreational and medicinal use in various global regions. At this time the USA is the most dominant market for cannabis and has shown to be a growing space. Many companies are effectively scaling their operations, expanding their product lines, and tapping into new markets.

All of which help to drive up their sales and overall profitability. Additionally, as more states and countries legalize cannabis, the potential customer base continues to grow, contributing to a positive outlook for established businesses in the sector. This has led to many seeing the future of where the money lies for marijuana stock investors. Yes, you can and some have formed a strategy off of waiting for pop amid a volatile downtrend.

But most want consistent upward trading and momentum which is the outlook at this time. Speculation has led to more buying in hopes that things will rise for the sector. The disconnect between the financial health of cannabis companies and the performance of their stocks can often be attributed to external market pressures. In addition to investor sentiment that doesn’t always align with the company’s operational success. Still, there is more of a positive outlook for how things could be, and that is the focus for most marijuana stock investors. Here are a few marijuana stocks to watch this week in the stock market.

The Top Public Cannabis Companies To Know

GrowGeneration Corp. (NASDAQ:GRWG)
The Scotts Miracle-Gro Company (NYSE:SMG)

GrowGeneration Corp.

GrowGeneration Corp., through its subsidiaries, owns and operates retail hydroponic and organic gardening stores in the United States. On March 4th the company announced it will be attending the 37th Annual ROTH Conference on March 16-18, 2025.

The company has mentioned it will be participating in the ROTH Conference located in Dana Point, California. The Company will conduct 1×1 meetings during the conference. Investors interested in scheduling a meeting with GrowGen management can request a meeting through ROTH MKM.

The Scotts Miracle-Gro Company

The Scotts Miracle-Gro Company, together with its subsidiaries, engages in the manufacture, marketing, and sale of products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. The company recently announced it has partnered with Columbus City Schools and The Ohio State University Extension for a gardening program.

This program has led to students trying new, fresh foods and recipes. In other news The Scotts Miracle-Gro Company also selected Jim Safka to lead ecommerce initiatives. Safka is an accomplished executive with extensive and pioneering experience in technology, marketing and management.

He previously served as CEO of Match.com, which grew by more than 20 percent annually under his leadership.

The post 2 Top Pot Stocks To Watch As More Companies Report Earnings appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Here Are Ways To Profit With Marijuana Stocks While Volatility Is High

MJ Shareholders — Fri, 14 Mar 2025 17:29:09 +0000

3 Cannabis Stocks That Could Be Game Changers for You In 2025

Those invested in cannabis stocks understand that taking profits has been a struggle. There is a hefty level of volatile trading that has kept the sector on a downward trend. This trend is what makes any sector, including cannabis nearly impossible to be profitable. At one time marijuana stocks showed healthy trading even in a down trend. Over the last few years, the trading behavior of public cannabis companies has changed drastically.

Still, the cannabis industry as a whole is thriving, and most companies are reporting strong earnings even in the down market. However, there is hope of seeing profits in the future through several key steps. So, if you are looking to leverage the volatile downtrend, buy the dips and remain patient. The key here is to catch a volatile bounce that, although short-lived, can be a profitable moment. Now, these bounces have been far few and in between but is a strategy nonetheless.

The other is prepping for the future of cannabis, as that is where much of the hope and positive speculation lives. Studying the sector and identifying trends and indicators as best you can will be an asset to protect your shares. You should look to protect, diversify, and grow your portfolio as best as you can. The marijuana stocks to watch below could offer value toward future profits as a cannabis investor.

Marijuana Stocks For Your 2025 Watchlist

Curaleaf Holdings, Inc. (OTC:CURLF)
Green Thumb Industries Inc. (OTC:GTBIF)
Verano Holdings Corp. (OTC:VRNOF)

Curaleaf Holdings, Inc.

Fourth Quarter 2024 Financial Highlights

Net Revenue of $331.1 million, a year-over-year decrease of 4% compared to Q4 2023 revenue of $345.3 million.
Gross profit of $157.4 million and gross margin of 48%, an increase of 230 basis points year-over-year.
Adjusted gross profit(1) of $158.7 million and adjusted gross margin(1) of 48%, an increase of 150 basis points year-over-year.
Cash at quarter end totaled $107.2 million.

Green Thumb Industries Inc.

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. In recent news, the company has released its social impact report.

The 2024 Social Impact Report documents and celebrates Green Thumb’s continued efforts to drive progress across four key pillars of the Company’s “Growing For Good” program. This includes Community Engagement, Inclusion & Belonging, Restorative Justice, and Environmental Stewardship.

Words From The Company

“The ‘Growing For Good’ program is not simply a philanthropic arm of Green Thumb; it’s a reflection of our entire culture and our shared responsibility to give back to the communities we serve,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.”

Verano Holdings Corp.

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. Recently the company reported 2024 forth quarter financials.

Q4 2024 Earning Highlights And Key Mentions

Revenues, net of Discounts, of $218 million, a decrease of 8% year-over-year, and an increase of 1% versus the prior quarter.
Gross profit of $108 million or 49% of revenue.
SG&A expense of $84 million or 38% of revenue.
Net loss of $(273) million or (125)% of revenue.
Adjusted EBITDA1 of $63 million or 29% of revenue.
Net cash provided by operating activities of $44 million.
Capital expenditures of $14 million.

The post Here Are Ways To Profit With Marijuana Stocks While Volatility Is High appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Verano Holdings Corp. (VRNOF) Targets Industry’s Fastest-Growing Categories in Leading Cannabis Markets

MJ Shareholders — Thu, 13 Mar 2025 21:31:33 +0000

Verano Targets Industry’s Fastest-Growing Categories with Expansion of Savvy and (the) Essence Product Portfolios in Leading Cannabis Markets

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the launch of a wave of new product innovation across the fastest-growing categories in key markets, including Extra Savvy 2-gram vape cartridges; Savvy Strut 2-gram all-in-one vapes; Savvy 100 Proof diamond-infused barrel-style pre-rolled joints; and (the) Essence J’s barrel-style pre-rolled joints.

Pre-rolled joints and vapes represent the fastest-growing categories in the industry, and the larger-format vape category specifically grew more than 400% in 20241. Demonstrating Verano’s focus on innovation, automation and differentiation, the Company is moving with speed and agility to meet consumer demand by leveraging in-house talent and cutting-edge manufacturing technology that exponentially increases production efficiency and output while preserving quality.

“As consumer appetite for differentiated cannabis products increases, particularly in the vape and pre-roll categories, we are excited to unleash a wave of innovation across our Savvy and (the) Essence portfolios featuring unique styles, experiences and engagement,” said David Spreckman, Verano Chief Marketing Officer. “Following the initial rollout of (the) Essence J’s and Extra Savvy 2-gram vape carts in some of the nation’s largest cannabis markets, Extra Savvy White Widow was the top-selling vape in Illinois last month1, and with Savvy 100 Proof pre-rolls and Savvy Strut 2-gram all-in-one vapes also launching in key states, we are well-positioned to further elevate our strong market positions in the fastest-growing categories.”

The full suite of new Savvy and (the) Essence products will be available for purchase at Verano’s Zen Leaf and MÜV locations, along with third-party dispensary partners, in select states.

Extra Savvy 2-gram vape cartridges: Stacked with high potency oil and tasty terps to hit harder, last longer and stretch cash. Perfect for seasoned consumers who value potency, longevity and consistency in their vapes. Extra Savvy is currently available in five strains: Sour Tangie, White Widow, Bacio Gelato, Rainbow Belts and GMO. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania, Florida and Connecticut.

Savvy Strut 2-gram all-in-one vapes: The 2-gram all-in-one that delivers big clouds and bold flavors. Built to max out and make every drop count, with its USB-C compatibility, lit oil window and dynamic airflow for trouble-free vaping, Savvy Strut is perfect for consumers who value portability, longevity and consistency in their vapes. Each device includes an embedded NFC chip, which allows users to simply tap their smartphone to get plugged into exciting deals and promotions. Savvy Strut is currently available in six strains: Juicy Mango, Summer Melon, Peaches & Cream, Pineapple Mimosa, Fresh Berry and Rainbow Sherbet. Now available in Illinois, New Jersey, Maryland and Arizona; coming soon to Pennsylvania and Florida.

Savvy 100 Proof diamond-infused barrel-style pre-rolled joints: Locked and loaded for a heavier hit, Savvy 100 Proof is crafted by blending pre-ground small bud flower with superfine, isolated THCa diamonds. This infusion process ensures a seamless blend of beloved Savvy strains with the THCa diamonds, delivering a uniquely potent experience. Now available in Illinois and New Jersey.

(the) Essence J’s barrel-style pre-rolled joints: Tapping into the industry’s fastest-growing category, (the) Essence J’s harness the power of cutting-edge manufacturing innovation that exponentially increases output while incorporating a unique yet recognizable barrel-style shape, delivering consumer affordability without sacrificing quality. Now available in Illinois and New Jersey; coming soon to Florida.

Product images are available for media use and download here (credit “courtesy of Verano”): Savvy and (the) Essence new product images

About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners, including Cabbage Club, an innovative annual membership program offering exclusive benefits for cannabis consumers. Verano produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, (the) Essence, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 13 U.S. states, comprised of 15 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.

Media Contact:
Verano
Grace Bondy
Director, Communications
Grace.Bondy@verano.com

Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

The post Verano Holdings Corp. (VRNOF) Targets Industry’s Fastest-Growing Categories in Leading Cannabis Markets appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

3 Marijuana Stocks For Investors To Get Excited About

MJ Shareholders — Thu, 13 Mar 2025 01:30:02 +0000

Here Is What Could Shake Up The Cannabis Sector

Marijuana stocks are still feeling the burden of industry concerns that have impacted trading. The bigger, more upfront issue is reform and regulatory matters. As well as fears of what will come with President Trump being in office and parts of his staff not on board with the legal market. Yet, as all of this stands true, cannabis companies continue to thrive and show large amounts of profitability.

This continuous success is creating positive speculation amid a downtrend. Now, this occurring because even with a drop in trading, legal operators are making money. So, when looking into the future, it gives hope that this progress will continue until trading changes. Many have been playing off this di,p finding top marijuana socks to buy while waiting for the sector to bounce. The bounce people are hoping for is not a volatile spike but a consistent trend of upward trading.

As most know, nothing is set in stone, and anything can happen in the public sector. One of the best ways to limit risk and maximize profits is to do your research and establish a trading plan. Having a trading strategy in place is what can help deliver a more successful portfolio down the line. Below are several marijuana stocks to watch that could soon see a better market performance.

Top Marijuana Stocks To Watch 2025

Innovative Industrial Properties, Inc. (NYSE:IIPR)
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)
NewLake Capital Partners, Inc. (OTC:NLCP)

Innovative Industrial Properties, Inc.

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. On February 19th the company reported its Q4 2024 results.

Highlights And Keymentions

Total revenues of $308.5 million.
Total revenues of $76.7 million for the quarter.
Net income attributable to common stockholders of $159.9 million.
Adjusted funds from operations (AFFO) of $256.1 million.
Net income attributable to common stockholders of $39.5 million for the quarter, or $1.36 per share.
AFFO of $63.4 million, or $2.22 per share.

Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial real estate finance company in the United States. In recent news the company announced Q4 2024 earnings.

Fourth Quarter 2024 Financial Results

Net interest income of approximately $14.1 million as of December 31, 2024, compared to $14.5 million as of September 30, 2024.
Interest expense decreased by approximately $0.4 million due to lower weighted average borrowings during the comparative period ending September 30, 2024.
Total expenses of approximately $5.7 million before provision for current expected credit losses.
On a fully diluted basis, there were 21,240,464 and 20,060,677 common shares outstanding as of December 31, 2024 and September 30, 2024, respectively.

NewLake Capital Partners, Inc.

NewLake Capital Partners, Inc. is an internally-managed real estate investment trust that provides real estate capital to state-licensed cannabis operators through sale-leaseback transactions and third-party purchases and funding for build-to-suit projects.

Recently the company announced that Anthony Coniglio, President and CEO, will present at the Sidoti Virtual Investor Conference. This investors conference is set to be held March 19-20, 2025.

The post 3 Marijuana Stocks For Investors To Get Excited About appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

Cronos Group Inc. (CRON) to Speak at the 37th Annual Roth Conference

MJ Shareholders — Tue, 11 Mar 2025 09:29:18 +0000

Cronos Group Inc. to Speak at the 37th Annual Roth Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 37th Annual Roth Conference on Monday, March 17, 2025, at 1:00 PM PT.

Forward-looking Statements
This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Mr. Gorenstein’s intention to speak at the 37th Annual Roth Conference and Cronos’ intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.ca and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact
Anna Shlimak
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

The post Cronos Group Inc. (CRON) to Speak at the 37th Annual Roth Conference appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

3 Marijuana Stocks To Watch This Month As Trading May Begin To Build

MJ Shareholders — Mon, 10 Mar 2025 13:28:58 +0000

These Marijuana Stocks Could Be Worth Your Time And Money

Most marijuana stocks rely on the success of legal operators and a few other variables to build stronger trading. However, the true cure for the volatile downtrend and uncertainty is better laws and regulations. This issue has been a problem that has yet to be solved since cannabis first became legal in the US. Investors in the public space operate differently than most, and when there is fear or doubt, it can hinder how the flow of cannabis investing can go.

Looking back, when news on reform or regulation issues were being improved and worked on, it created healthy trading. People want to feel safe and limit as much risk, but they also do not want to miss out by not taking one either. Cannabis stocks are that happy medium as they operate more so in gray space where speculation is key. Right now, with how things are looking, the future of the industry is where most investors believe they will see better paydays.

As companies continue to show strong earnings and growth initiatives like new dispensaries, products, and strategic partnerships. When a person sees that a business can thrive and remain profitable it gives hope. Below are some marijuana stocks to watch if you find an interest in cannabis investing.

Top Marijuana Stocks For Your Watchlist Today

Jushi Holdings Inc. (OTC:JUSH)
Cresco Labs Inc. (OTC:CRLBF)
Trulieve Cannabis Corp. (OTC:TCNNF)

Jushi Holdings Inc.

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. On March 6th, the company released its Q4 and full 2024 yearly earnings.

Highlights And Key Mentions

Q4 2024

Total revenue of $65.9 million
Gross profit and gross profit margin of $25.4 million and 38.6%, respectively,
Net loss of $12.5 million
Cash, cash equivalents and restricted cash were $21.3 million as of quarter end
Net cash flows provided by operations of $7.2 million

Full 2024 Year

Total revenue of $257.5 million
Gross profit and gross profit margin of $118.3 million and 45.9%, respectively
Net loss of $48.8 million

Cresco Labs Inc.

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. Recently, the company announced it will operate Kentucky’s largest medical cannabis cultivation license.

The agreement entitles Cresco Labs to manage and operate a cultivation facility with up to 25,000 square feet of canopy. This is a significant milestone establishing Cresco Labs as one of only two operators of Kentucky’s coveted Tier 3 cultivation licenses.

Words From The Company

“I look forward to showing Kentucky residents why Cresco Labs’ portfolio is the most popular choice in both medical markets like Pennsylvania and adult use markets like Illinois. The Cultivation License allows for the construction of a state-of-the-art cultivation facility with up to 25,000 square feet of canopy, enabling us to deliver the quality and scale we are known for,” said Charlie Bachtell, CEO of Cresco Labs.”

Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries as well as through home delivery.

In recent news, the company announced the appointment of Ryan Blust as Interim Chief Financial Officer. The Company has also retained the services of an executive recruitment firm.

Words From Kim Rivers

“We thank Wes for his good work, particularly with his team implementing robust financial controls to meet Sarbanes Oxley requirements last year,” said Trulieve’s Chief Executive Officer Kim Rivers.”

The post 3 Marijuana Stocks To Watch This Month As Trading May Begin To Build appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..

High Tide Inc. (HITI) to Open Two New Canna Cabana Stores in Ontario

MJ Shareholders — Mon, 10 Mar 2025 13:28:57 +0000

High Tide to Open Two New Canna Cabana Stores in Ontario

High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 99 Balsam Street in Collingwood, ON will begin selling recreational cannabis products and consumption accessories for adult use on March 13, 2025; and that its Canna Cabana retail cannabis store located at 1 Hespeler Road in Cambridge, ON will begin selling recreational cannabis products and consumption accessories for adult use on March 17, 2025. These openings will mark High Tide’s 193rd and 194th Canna Cabana branded retail cannabis locations in Canada, and the 78th and 79th in the province of Ontario.

COLLINGWOOD LOCATION

Our first store in Collingwood is strategically situated in the heart of town, which is a popular tourist destination with 400,000 unique visitors annually. Situated in the Collingwood Centre alongside high-traffic national hardware and grocery chains, the location benefits from strong foot traffic and excellent co-tenancy. Positioned on the route to Blue Mountain Village, it serves as the first cannabis store travelers encounter as they enter Collingwood, providing easy access for both locals and tourists.

CAMBRIDGE LOCATION

Our first store in Cambridge is perfectly situated in a prime location, with access to a strong population density with limited nearby competition. Located at a major intersection and thoroughfare, the store is anchored by popular national fast food, retail and coffee chains, drawing significant foot traffic from the large residential neighbourhoods nearby.

“We are thrilled to be expanding our footprint in Ontario with these two new Canna Cabana locations in Collingwood and Cambridge. Each store has been carefully selected to serve both local communities and visitors, offering them a welcoming and accessible retail experience. Our Collingwood store, situated at a key entry point to this popular tourist destination, will cater to the thousands of travelers who visit the area each year, while our Cambridge location benefits from a strong residential base and high-traffic commercial setting. With every new store, we are reinforcing our commitment to making legal cannabis more accessible and affordable across Canada,” said Raj Grover, Founder and Chief Executive Officer of High Tide.

“As we approach the milestone of 200 stores nationwide, High Tide remains focused on delivering unmatched value through our innovative discount club model, unbeatable prices, and exclusive Cabana Club benefits. Our goal is to create a shopping experience that is both engaging and enjoyable, ensuring that our loyal members receive the best products at the best prices in a safe and welcoming environment. We look forward to serving these vibrant communities and continuing to set the standard for cannabis retail in Canada,” added Mr. Grover.

STOCK OPTIONS GRANT

In addition, High Tide announces the grant of 25,000 incentive stock options (the “Options”) to consultants of the Company. Each Option is exercisable at the closing price of the Company’s common shares listed on the TSX Venture Exchange (the “TSXV”) based on the last trading day immediately prior to this press release, expires two years from the date of grant, and vests over a one-year period. Each Option is exercisable to purchase one common share of the Company and are being issued pursuant to the terms of the Company’s Omnibus Plan, which became effective on June 2, 2022.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world’s most powerful plant and is the second-largest cannabis retailer globally by store count1. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Bricks & Mortar Retail: Canna Cabana is the largest cannabis retail chain in Canada, with 194 current locations spanning British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and growing. In 2021, Canna Cabana became the first cannabis discount club retailer in the world.

Retail Innovation: Fastendr is a unique and fully automated technology that employs retail kiosks to facilitate a better buying experience through browsing, ordering and pickup.

Consumption Accessories: High Tide operates a suite of leading accessory e-commerce platforms across the world, including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com.

Brands: High Tide’s industry-leading and consumer-facing brand roster includes Queen of Bud, Cabana Cannabis Co, Daily High Club, Vodka Glass, Puff Puff Pass, Dopezilla, Atomik, Hue, Evolution and more.

CBD: High Tide continues to cultivate the possibilities of consumer CBD through Nuleafnaturals.com, FABCBD.com, blessedcbd.de and blessedcbd.co.uk.

Wholesale Distribution: High Tide keeps that cannabis category stocked with wholesale solutions via Valiant.

Licensing: High Tide continues to push cannabis culture forward through fresh partnerships and license agreements under the Famous Brandz name.

High Tide consistently moves ahead of the currents, having been named one of Canada’s Top Growing Companies by the Globe and Mail’s Report on Business in 2024 for the fourth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas’ Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don’t miss the High Tide profile pages on SEDAR+ and EDGAR.

_______________________________

1 As reported by ATB Capital Markets based on store counts as of February 6, 2025

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CONTACT INFORMATION

Media Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain “forward-looking information” and “forward-looking statements within the meaning of applicable securities legislation. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the timing of our new locations beginning to sell recreational cannabis products and consumption accessories for adult use, the expected benefits of the store locations, and our commitment to opening the number of future stores on the timeline indicated herein. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company’s control, including but not limited to the risk factors discussed under the heading “Non-Exhaustive List of Risk Factors” in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-open-two-new-canna-cabana-stores-in-ontario-302396395.html

SOURCE High Tide Inc.

The post High Tide Inc. (HITI) to Open Two New Canna Cabana Stores in Ontario appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry..